SCD411
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SCD411, covering 2023-10-10 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy [Phase 2]